ask="100.00"
ask_size="200"
average_daily_volume="471926"
bid="83.05"
bid_size="100"
book_value="11.49"
change="-0.08"
change_from_200_day_moving_average="13.85"
change_from_50_day_moving_average="11.61"
change_from_52_week_high="-2.14"
change_From_52_week_low="38.56"
change_in_percent="-0.09%"
close="85.08"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38556000"
high="87.22"
high_52_weeks="87.22"
last_trade_date="2/28/2017"
last_trade_price="85.08"
last_trade_size="149327"
last_trade_time="4:00pm"
low="83.09"
low_52_weeks="46.52"
market_capitalization="3.55B"
moving_average_200_day="71.23"
moving_average_50_day="73.47"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="95.06"
open="84.65"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+19.45%"
percent_change_from_50_day_moving_average="+15.80%"
percent_change_from_52_week_high="-2.46%"
percent_change_from_52_week_low="+82.89%"
previous_close="85.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.41"
price_per_sales="26717.19"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="728383"
weeks_range_52="46.52 - 87.22"
